This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
6 questions investors should ask when evaluating psychedelic biotech companies. 6 questions investors should ask when evaluating psychedelic biotech companies. ” Terra will back UST with additional Layer 1 blockchains as it expands its ecosystem, said Kwon. Image Credits: Yarygin (opens in a new window) / Getty Images.
Multidomain integration is becoming a cornerstone of modern software development, bridging technologies like blockchain, biotech, and consumer applications. These cross-domain projects are no longer optional they are the future of innovation. However, combining such diverse systems presents unique challenges.
Dragonfly plans to focus its investments across all stages of blockchain and crypto-native companies, protocols, and tokens. “We It’s like investing in crypto without understanding technology is like investing in biotech without understanding biology. You’d be missing the core mechanics of what you’re investing in.”.
billion in its fourth fund targeting blockchain, bringing its total funds raised for blockchain-related companies to more than $7.6 billion allocated to biotech investments. Founders Fund in March raised over $5 billion across venture ($1.9 billion) and growth ($3.4 billion) funds. a16z in May raised about $4.5
Deep tech, medtech/biotech, climate tech, and crypto and blockchain are all areas that investors say they’re either actively investing in or watching for signs of scale. Blockchain NZ Chair Bryan Ventura. Now, certain industries are emerging as potential areas where New Zealand can win in the tech space.
Not surprisingly, those two rounds came from the cybersecurity and biotech industries. Eikon Therapeutics , $351M, biotech: Eikon Therapeutics raised one of the biggest biotech rounds thus far in this young year. Raise , $63M, loyalty: Miami-based Raise, a gift cards and loyalty company, raised $63 millionled by Haun Ventures.
HealthTech + BioTech. FinTech + Blockchain. These rising-star startups represent the innovation taking place across these tech categories: Hardware, Robotics, AI + ML. Space + Security. SaaS, Enterprise + Retail. Education, HR + Future of Work. Climate + CleanTech. Mobility + Transportation. Want to see the companies?
Monad Labs , $225M, blockchain: New York-based Monad Labs locked up the biggest Web3 funding round of the year thus far, collecting a $225 million funding round led by Paradigm. Monad is a layer-1 blockchain that is compatible with the Ethereum Virtual Machine but can process transactions using the same set of rules faster.
Like a museum, but on the blockchain : Despite his usual misgivings for crypto tech, we spot Haje covering a rare blockchain story, about Arkive, and its building of the world’s first decentralized museum. OnlySims : A first for OnlyFans, the platform invests in U.K. creator Chloe Sims and her sisters , reports Lauren.
Indeed, portfolio includes companies in a range of industries such as fintech, enterprise/SaaS, proptech, insuretech, health tech, edtech, e-commerce, food tech, climate tech, biotech and blockchain.
Halda Therapeutics , $126M, biotech: The big biotech round of the week came from New Haven, Connecticut-based Halda Therapeutics, a biotech startup developing therapies for prostate cancer and breast cancer, which raised a $126 million Series B extension from investors including Deep Track Capital and RA Capital Management.
Nevertheless, the week saw a $1 billion round go to yet another AI startup, and biotech and blockchain also saw some big deals. AltruBio , $225M, biotech: AltruBio was the biggest biotech raise of the week, securing a $225 million Series B led by BVF Partners. Farcaster , $150M, blockchain: Is Web3 funding back?
April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. A startup needed to raise $200 million or more to break into this list for the April edition. Let’s take a look.
Investors certainly put their money everywhere, from biotech to productivity tools, but they didn’t shell out a lot. Pathalys Pharma , $105M, biotech: Raleigh, North Carolina-based Pathalys Pharma isn’t new to this list — it topped it early last year. Another slow week with only three companies raising rounds of more than $100 million.
Mirador Therapeutics , $400M, biotech: More big biotech raises this week. Capstan Therapeutics , $175M, biotech: Capstan Therapeutics raised a $175 million Series B led by RA Capital Management. Clasp Therapeutics , $150M, biotech: Clasp Therapeutics is the next biotech to raise huge. billion, per Crunchbase.
Web3 Berachain , an Ethereum-compatible blockchain for financial applications, raised $69 million by selling digital tokens led by BH Digital and Framework Ventures. The bear-themed blockchain company based in the Cayman Islands was valued at $1.5 Let’s look at March’s new unicorn startups by sector. billion in the deal.
CinRx Pharma , $73M, biotech: This week’s top biotech round isn’t as big as it is on most weeks, but that follows the general trend. BabylonChain , $70M, blockchain: Palo Alto, California-based BabylonChain, a developer of security protocols for decentralized systems, completed a $70 million round led by Paradigm.
Zephyr AI , $111M, biotech: Mclean, Virginia-based healthcare startup Zephyr AI closed a $111 million Series A from investors that included Revolution Growth and Eli Lilly & Company. Like many biotech startups raising big money currently, Zephyr is bringing AI to the sector. billion.
However, the city’s tech scene is apparently lackluster when it comes to legal tech, blockchain and consumer-facing technology. Weak in blockchain and consumer. Weak in deep tech discovery, especially in biotech/therapeutics. This offer is only available to readers in the UK Europe and expires on June 30, 2021.
Terray Therapeutics , $120M, biotech: Los Angeles-based Terray Therapeutics, a biotech startup developing small molecule drug therapeutics, raised a $120 million Series B led by new investor Bedford Ridge Capital and existing investor NVentures. Founded in 2021, the company has raised nearly $318 million, per Crunchbase.
The city appears to be strong in areas such as travel, AI, cybersecurity, fintech, agritech, travel tech, biotech, sports tech, and VR. The blockchain/crytpo scene could do with some improvement, according to a few respondents. Blockchain could be improved. Helena Ortiz Gil, CMO, Techer Team. What are you most excited by?
The Great Expectations of Crypto and Blockchain , with MoneyGram. Web3, Crypto, Blockchain — Unlocking Prosperity for Tech and Creative Industries in Africa , with Fast Forward Venture Studio. BF 200 Fast-Pitch Sessions — Heath Tech and Biotech. . BF 200 Fast-Pitch Sessions — Fintech, Blockchain, Space and Security. .:
The investment scene is described variously as focusing on software, clean tech, life sciences, biotech, organoids, 3D bioprinting, AI and VR/AR. A lot of focus is on life sciences, biotech, as there is a lot of research at the Utrecht science park and also spin-offs. It just goes to show the region has a strong and growing ecosystem.
The startup’s blockchain network allows IP owners to store their IP on the platform, embedding terms to use it — such as licensing fees — into smart contracts. Basically, the blockchain aims to ensure owners are compensated when their IP is used. The new round reportedly values the company at $2.25 Series F Illustration: Dom Guzman
Web3 Blockchain platform Berachain , a 2-year-old company based in the Cayman Islands, raised a $100 million Series B. The company is a layer 1 blockchain that can process Ethereum transactions faster. The 4-year-old company based in Los Angeles was valued at $1.2
Data61, Treasury to review the future of blockchain technology in Australia - ZDNet. Designer proteins open up biotech frontiers. Katie Kennedy. The following are some of the hot topics we are tracking in the technology ecosystem: Technology Ticker. GeekWire Deals: Use Alexa or your phone to control your TV with the Blumoo IR blaster.
Blockchain for cross-border trading. Blockchain is revolutionizing the Agriculture sector in many ways including trading commodities on the blockchain is helping to reduce middlemen interference by promoting a peer-to-peer model of connecting farmers with end users. Weather forecasts. Automated irrigation.
Privacy and security Two-year-old Andalusia Labs , a risk management provider for digital assets in crypto and blockchain technologies, raised a $48 million Series A led by Lightspeed Venture Partners. Alongside this funding, the company set up new headquarters in Abu Dhabi and was valued at $1 billion.
Other investors felt that a broader range of industries, like fintech and biotech, would eventually produce the biggest companies in the country. Blockchain is a difficult sector because it lacks a clear regulatory environment, subsequently raising many questions. We are more cautious about particular industries.
Eigen Labs , $100M, blockchain: Seattle-based Eigen Labs, the creator of EigenLayer for staking Ethereum, raised a $100 million round from a16z crypto. Last year such startups saw only $1.2 billion in 66 deals — per Crunchbase data — after raking in more than $2 billion in 2022. This year has seen only a trickle of deals.
Cutting- edge t echnologies : We leverage advanced technologies such as AI, IoT, blockchain, and biotech, through our extensive network of partners and innovation hubs. Cultural t ransformation : We support organizational change with training, coaching, and change management to foster a culture of sustainability and innovation.
The events cover domains such as big data, cybersecurity, blockchain, and cryptocurrency. The scope includes companies working with machine learning, fintech, biotech, cybersecurity, smart cities, voice recognition, and healthtech. TechAlpharetta. Tech Alpharetta’s Innovation Centre.
Stämm Biotech raises $17M : Have you heard of bioreactors? I’m not surprised at the ratio, and the rising tally of international companies that it implies. My question is how quickly the portion of high-value Y Combinator-backed startups moves towards being majority international.
Happy Monday Matches employees with purpose-driven organizations Hacken Hacken, the blockchain cybersecurity firm, has also been working on tools to help Ukraine cyber warfare efforts and combat Russian propaganda.
Buterin, better known as one of the creators of the Ethereum blockchain, is investing around $15 million in USDC stablecoin via the $100 million Balvi fund , which he set up earlier this year specifically for COVID research projects. None of this comes for free, of course, which is where today’s funding announcement comes into play.
Pharma/Biotech: $3,295. Below you’ll find the list of conferences taking place in Q1 and Q2. Now in its 10th year, the conference has one of the most impressive and distinct speaker schedules of 2019; its list includes individuals working in network, provider, non-profit, startup, and government roles. Cost to Attend: . Standard: $3,595.
Bankrolling the Blockchain with a16z Crypto. Launched in 2020, Solana gained worldwide renown for being one of the fastest blockchains with a rapidly growing developer ecosystem. The Great Expectations of Crypto and Blockchain. But first, he’s tackling another problem: soggy delivery. Speeding Up Crypto. Sponsored by: AWS.
Launched in 2020, Solana gained worldwide renown for being one of the fastest blockchains with a rapidly growing developer ecosystem. Join leaders in the AI-Driven Drug Discovery market for a fireside chat exploring how to build the next-generation of digital biotech. Speeding Up Crypto. Disrupt Stage | 1:45 pm.
Jara, Chief Scientific Officer de Libelium; Alejandro Expsito, CIO y COO de la biotech Servatrix Biomed; y Zigor Gaubeca, CIO de Grupo Aire. Anticipamos un aumento en el nivel de inversin en el sector TI para 2025, explica Alejandro Expsito, CIO y COO de la biotech Servatrix Biomed. Se gastar ms en tecnologa?
Its preferred sectors are ‘techbio’ (by which he means tech-focused biotech businesses), software (especially software as a service, or SAAS), energy and fintech. It likes to invest in platforms, and picks and shovels, which means businesses which can become part of the essential infrastructure for many larger companies.
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content